Merck & Co., Inc. (MRK) Balance sheet
Top 20 of 39 line items reported by MRK · 250+ in the full API →
Merck & Co., Inc. (MRK) · Balance Sheet
Consolidated Balance Sheets
Annual · In millions USD · Latest as of Dec 31, 2025
| As of | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Total Assets | $136,866 | $117,106 | $106,675 | $109,160 | |
| Total Current Assets | $43,516 | $38,782 | $32,168 | $35,722 | |
| Property, Plant & Equipment, net | 25,316 | 23,779 | 23,051 | 21,422 | |
| Operating leased assets | 1,507 | 1,370 | 1,437 | 1,346 | |
| Goodwill | 21,579 | 21,668 | 21,197 | 21,204 | |
| Intangible assets | 26,681 | 16,370 | 18,011 | 20,269 | |
| Other long-term assets | 18,818 | 16,044 | 11,996 | 9,528 | |
| Total Liabilities | $84,260 | $70,793 | $69,094 | $63,169 | |
| Total Current Liabilities | $28,327 | $28,420 | $25,694 | $24,239 | |
| Long-term debt | 46,750 | 34,462 | 33,683 | 28,745 | |
| Deferred income taxes | 1,439 | 1,387 | 871 | 1,795 | |
| Operating lease liabilities | 901 | 877 | 928 | 1,013 | |
| Pension & retiree benefits | 131 | 140 | 158 | 202 | |
| Other long-term liabilities | 7,688 | 6,465 | 8,792 | 8,323 | |
| Total Shareholders' Equity | $52,606 | $46,313 | $37,581 | $45,991 | |
| Common Stock | 1,788 | 1,788 | 1,788 | 1,788 | |
| Current Ratio | 1.54 | 1.36 | 1.25 | 1.47 | |
| Quick Ratio | 0.93 | 0.84 | 0.68 | 0.93 | |
| Debt-to-Equity Ratio | 0.94 | 0.80 | 0.93 | 0.67 | |
| Working Capital | 15,189 | 10,362 | 6,474 | 11,483 | |
19 more line items available via the API
Cash & Short-Term InvestmentsCash & EquivalentsShort-Term InvestmentsAccounts ReceivableInventoryOther Current AssetsAccounts PayableCurrent DebtCurrent Portion of Long-Term DebtIncome Taxes PayableOther Current LiabilitiesAdditional paid-in capitalTreasury stock, at costRetained EarningsAccumulated other comprehensive incomeAllowance for doubtful accountsDTA valuation allowanceRestricted cash & equivalentsUnrecognized tax benefits